The Sugar-Funded Fat-Heart Verdict — Big Sugar Bought the 1967 Conclusion, Exposed in 2016

On the pages of The New England Journal of Medicine in 1967, three Harvard nutrition scientists — Robert McGandy, D. Mark Hegsted, and department chair Fredrick Stare — published a two-part review, “Dietary Fats, Carbohydrates and Atherosclerotic Vascular Disease,” that declared there was “no doubt” the only dietary change needed to prevent coronary heart disease was to cut saturated fat and cholesterol. What the review did not say, and what its readers could not know, was that it had been commissioned, paid for, and editorially steered by the Sugar Research Foundation, the sugar industry’s trade body, which had set the review’s objective in advance precisely to deflect a rising scientific suspicion that its own product — sucrose — drove heart disease. The promise was an authoritative, disinterested survey of the evidence; the reality was a literature review with a sponsor who had already approved the answer.

The mechanism was exposed nearly half a century later. In September 2016, UCSF researchers Cristin Kearns, Laura Schmidt, and Stanton Glantz published an analysis in JAMA Internal Medicine of more than 340 industry documents totaling 1,582 pages. The papers showed that the Sugar Research Foundation paid the authors roughly $6,500 — about $48,000–$50,000 in 2016 dollars — under the codename “Project 226,” supplied the articles to be reviewed, defined the objective, and read drafts. The foundation’s vice-president for research, John Hickson, told the authors his interest lay in answering claims “that carbohydrates in the form of sucrose make an inordinate contribution,” and wrote that he would be “disappointed if this aspect is drowned out.” On 2 November 1966 Hickson pronounced a draft “quite what we had in mind.” None of this appeared in the published paper.

The cost was not a single bad study but a generation of misdirected emphasis. The NEJM at the time required no conflict-of-interest disclosure, so the review entered the literature as neutral science and helped anchor a five-decade national focus on dietary fat while sugar’s cardiometabolic role went comparatively under-investigated. Hegsted later became a key architect of U.S. federal dietary guidance, including the 1977 Dietary Goals for the United States. The findings were never formally retracted — the review remains in the record — but its evidentiary standing collapsed once the funding and editorial control were documented.

This dossier records “Overturned” entry TH-005 as the archetype of the captured review: not a forged dataset but a curated one, in which the harm was the silent purchase of a conclusion and the institutional norm — no disclosure required — that let the purchase pass as scholarship for forty-nine years.